FollowTheFilings

Managers Activity Compare Newest

Investment

CRISPR THERAPEUTICS AG

Historical 13F holders

CUSIP: H17182108
Type: Equity
Class: NAMEN AKT

Period	13F filings
2026 Q1	8
2025 Q4	11
2025 Q3	9
2025 Q2	8
2025 Q1	10
2024 Q4	8
2024 Q3	12

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.